Dr. Raphael Koch
Claim this profileUniversitätsmedizin Göttingen
Studies Myelodysplastic Syndrome
1 reported clinical trial
2 drugs studied
More about Raphael Koch
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Raphael Koch has experience with
- Azacitidine
- Tamibarotene
Breakdown of trials Raphael Koch has run
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raphael Koch specialize in?
Raphael Koch focuses on Myelodysplastic Syndrome and other conditions. In particular, much of their work with Myelodysplastic Syndrome has involved RARA positive patients, or patients who are undergoing treatment.
Is Raphael Koch currently recruiting for clinical trials?
No, Raphael Koch is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Raphael Koch has studied deeply?
Yes, Raphael Koch has studied treatments such as Azacitidine, Tamibarotene.
What is the best way to schedule an appointment with Raphael Koch?
Apply for one of the trials that Raphael Koch is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.